Skip to content

Colonoscopy Check-up in People With Lynch Syndrome

Prevalence, Determinants, and Challenges of Adherence With Colonoscopy Check-up in People With Lynch Syndrome: a Questionnaire-based Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06126120
Enrollment
231
Registered
2023-11-13
Start date
2024-01-17
Completion date
2024-12-31
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lynch Syndrome

Keywords

Lynch Syndrome, Colonoscopy, Surveillance

Brief summary

Lynch syndrome, an inherited condition, increases bowel cancer risk. People with Lynch syndrome are recommended to have regular colonoscopies where a camera in a tube is used to look inside the bowel for cancer and for polyps (growths that sometimes can become cancerous). UK guidelines recommend that people with Lynch syndrome have colonoscopy check-up every 2 years after reaching a certain age; however, they face many challenges which make it difficult to have the recommended check-up. Among a subset of people with Lynch syndrome in England, this study investigated the: * percentage who underwent colonoscopy check-up as recommended by UK guidelines * factors influencing whether a person is more/less likely to have the recommended colonoscopy check-up * views, experiences, and challenges of living with Lynch syndrome and undergoing colonoscopy check-up This study collected information from people in the 'Lynch syndrome research registry pilot' using a questionnaire. The Cancer Screening and Prevention Research Group (CSPRG) at Imperial College London set up the Lynch syndrome research registry pilot, which included adults with Lynch syndrome who had previously participated in the Cancer Prevention Programme 3 (CaPP3) trial. The present study included people who took part in the Lynch syndrome research registry pilot, provided consent to be contacted about future research, and were aged ≥25 years. People who had undergone surgery to remove their rectum were excluded. The investigators used the 'Views, experiences, and challenges of colonoscopy check-up questionnaire', together with a few pieces of additional information previously collected as part of the Lynch syndrome research registry pilot. Participation involved completing the questionnaire only. The study was completed over approximately one year from administering the questionnaire in January 2024 to sharing results with participants in December 2024.

Interventions

None listed

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* People in the Lynch syndrome research registry pilot who provided consent to be contacted about future research and were aged ≥25 years

Exclusion criteria

* People who had undergone surgery involving removal of their rectum

Design outcomes

Primary

MeasureTime frameDescription
Participant Non-adherence to 2-yearly Colonoscopy Check-up.Up to approximately 13 years (median 5 years), based on the interval(s) between participants' 2 or 3 most recent check-up colonoscopies and the interval between participants' most recent check-up colonoscopy and questionnaire completion.Participant non-adherence to 2-yearly colonoscopy check-up was assessed using data from the national Hospital Episode Statistics (HES) database. Non-adherence was calculated based on the interval(s) between participants' 2 or 3 most recent check-up colonoscopies, depending on data availability, and the interval between participants' most recent check-up colonoscopy and questionnaire completion. Colonoscopy data recorded between December 1995 (when the earliest colonoscopy was recorded in the HES extract) and April 2024 (the final month in which participants completed the questionnaire) were used. Participant non-adherence was reported as a percentage.

Secondary

MeasureTime frameDescription
The 4 Most Important Challenges to Having Colonoscopy Check-up for Participants.At time of questionnaire (1 day)The 4 most important challenges to having colonoscopy check-up were identified using participants' responses in the questionnaire. The questionnaire asked participants to select up to 4 challenges they considered most important from a given list of 41 challenges. The 4 challenges most frequently selected by participants were considered the most important. The results show, for each challenge, the number and proportion of participants who selected it as one of their biggest challenges. As participants could select more than one challenge, the counts and percentages for individual challenges do not sum to the total number of participants and 100%, respectively.

Countries

United Kingdom

Contacts

PRINCIPAL_INVESTIGATORAmanda J Cross, PhD

Imperial College London

Participant flow

Recruitment details

Participants were recruited from the Lynch syndrome research registry pilot between 17 January 2024 and 4 April 2024.

Pre-assignment details

Of the 257 people in the registry pilot, seven were excluded at the initial participant eligibility assessment. The remaining 250 people were invited to take part in the present study, of whom 19 were subsequently excluded, either because the investigators were informed after invite that they met the exclusion criteria or because they did not respond to the questionnaire. This left 231 participants (92% of invitees). Participants were not assigned to any group or intervention.

Baseline characteristics

Characteristic
Age, Customized
Age group
25-44 years
40 Participants
Age, Customized
Age group
45-64 years
123 Participants
Age, Customized
Age group
≥65 years
68 Participants
Race/Ethnicity, Customized
Ethnicity
Other
11 Participants
Race/Ethnicity, Customized
Ethnicity
White British
220 Participants
Sex: Female, Male
Female
121 Participants
Sex: Female, Male
Male
110 Participants
Site
A
55 Participants
Site
B
60 Participants
Site
C
79 Participants
Site
D
37 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026